The NF-κB pathway is induced by a wide variety of stimuli, including cytokines such as the tumor necrosis factor-alpha and interleukin-1β, both of which are the targets of biologic therapies used to treat rheumatoid arthritis and juvenile idiopathic arthritis [43, 44]. This evidence concerns the gene NFKB1 and rheumatoid arthritis.